# US 8,278,484 B2 · Process for preparing a benzoylbenzeneacetamide derivative

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,484 B2
- Document ID: US8278484B2
- Status: Granted
- Kind: B2
- Application number: 12/483,839
- Filed: 2009-06-12
- Published: 2009-12-17
- Granted: 2012-10-02
- Earliest claimed: 2008-06-13
- Assignees: Medichem, S.A.
- Inventors: Gabriel Tojo Suárez; Ana Gavaldá Escudé
- Web page: https://patentgrep.com/patent/US8278484B2

## CPC

- C07C 319/20: by reactions not involving the formation of sulfide groups
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C07C 237/20: the carbon skeleton containing six-membered aromatic rings
- C07C 323/60: with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed is a process for preparing anti-inflammatory compound nepafenac comprising preparing a compound of formula (V) wherein a N-halosuccinimide is used as the halogenating agent, followed by desulfurization using Raney Nickel. Also disclosed is a polymorphic form B of 2-amino-3-benzoyl-α-(methylthio)-benzeneacetamide (i.e., a compound of formula (V) wherein R is methyl

## Claims

### Claim 1

A process for preparing a compound of formula V:
said process comprising
i) reacting a compound of formula (VI):
with an N-halosuccinimide compound and 2-aminobenzophenone of formula (II):
wherein R is an alkyl or aryl group, in the presence of an organic solvent, to obtain a reaction mixture;
ii) treating the reaction mixture with a base to obtain a mixture comprising compound (V), and
iii) optionally, isolating a compound (V) from the mixture.

### Claim 2 (depends on 1)

The process of claim 1, wherein the N-halosuccinimide is N-chlorosuccinimide.

### Claim 3 (depends on 1)

The process of claim 1, wherein R is methyl, 1-propyl, 2-propyl, or phenyl.

### Claim 4 (depends on 1)

The process of claim 1, wherein the compound (VI) is methylthioacetamide and the compound (V) is 2-amino-3-benzoyl-α-(methylthio)-benzeneacetamide.

### Claim 5 (depends on 1)

The process of claim 1, wherein the organic solvent is anhydrous.

### Claim 6 (depends on 1)

The process of claim 1, wherein the organic solvent of step i) is acetonitrile or dichloromethane.

### Claim 7 (depends on 1)

The process of claim 1, wherein the base of step ii) is an organic base.

### Claim 8 (depends on 7)

The process of claim 7, wherein the organic base is a trialkylamine or an aryldialkylamine.

### Claim 9 (depends on 8)

The process of claim 8, wherein the organic base is a trialkylamine.

### Claim 10 (depends on 9)

The process of claim 9, wherein the trialkylamine is triethylamine.

### Claim 11 (depends on 4)

The process of claim 4, wherein the organic solvent of step i) is dichloromethane, and the compound (V) isolated in step iii) is compound (IV) in polymorphic Form A:

### Claim 12 (depends on 4)

The process of claim 4, wherein the organic solvent of step i) is acetonitrile, and the mixture comprising compound (V) of step ii) is a suspension comprising compound (V) wherein said compound V is characterized by an X-ray powder diffraction pattern (2θ) having characteristic peaks at approximately 4.2, 4.8, 5.9, 6.8, 7.9, 10.4, 11.3, 12.5, 13.7, 13.9, 14.4, 15.4, 16.7, 17.2, 17.7, 18.5, 19.2, 19.6, 20.1, 20.6, 21.3, 21.5, 22.2, 23.4, 24.0, 25.1, 25.7, 26.3, 26.9, 27.5, 29.5, 30.1, 32.6, 34.3, 35.8, and 37.8 degrees 2θ (±0.2 degrees).

### Claim 13

Compound of formula (IV) polymorphic Form B:
having an X-ray powder diffraction pattern (2θ) having characteristic peaks at approximately 4.2, 4.8, 5.9, 6.8, 7.9, 10.4, 11.3, 12.5, 13.7, 13.9, 14.4, 15.4, 16.7, 17.2, 17.7, 18.5, 19.2, 19.6, 20.1, 20.6, 21.3, 21.5, 22.2, 23.4, 24.0, 25.1, 25.7, 26.3, 26.9, 27.5, 29.5, 30.1, 32.6, 34.3, 35.8, and 37.8 degrees 2θ (±0.2 degrees).

### Claim 14 (depends on 12)

The process of claim 12, which produces a compound of formula (V) in polymorphic Form B.

### Claim 15

A process for preparing compound of formula (IV) polymorphic Form B:
said process comprising
i) crystallizing compound of formula (IV) in a solvent comprising methyl isobutyl ketone to obtain a suspension, and
ii) removing the solvent from the suspension.

### Claim 16 (depends on 1)

The process claim 1, said process further comprising:
iv) reacting a compound of formula (V), with Raney nickel in the presence of a solvent, thereby obtaining a mixture comprising 2-amino-3-benzoylbenzeneacetamide (nepafenac) of formula (I):
v) isolating nepafenac from the mixture;
vi) optionally, recrystallizing nepafenac;
vii) optionally, treating nepafenac with at least one metal scavenger; and
viii) optionally, reducing particle size of nepafenac.

### Claim 17 (depends on 16)

The process of claim 16, wherein step v) is performed in a filter reactor.

### Claim 18 (depends on 16)

The process of claim 16, wherein the solvent of step iv) is tetrahydrofuran or a mixture of tetrahydrofuran and water.
